NCT02984124CompletedPhase 2/3
Communication During Hospitalization About Resuscitation Trial
Source: ClinicalTrials.gov · Last updated 29 May 2026
Brief summary (registry, in English)
This multicenter RCT of 200 hospitalized patients and their family members evaluates an "informed assent" approach to discussing cardiopulmonary resuscitation, compared to usual care, in older seriously ill hospitalized patients with severe life-limiting illness or severe functional impairment.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 182 (actual)
- First submitted
- 28 Nov 2016
- Start date
- 1 Dec 2016
- Primary completion date
- 31 Mar 2023
- Lead sponsor
- University of Vermont
- Diseases
- Chronic kidney disease, Heart failure
- NCT number
- NCT02984124
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 182
- From 1 Dec 2016 to the primary completion date, 31 Mar 2023
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently listed on a transplant list (awaiting transplant)
- Patient discharged from hospital prior to enrollment
Other
- Has already definitively chosen DNR status
- Unable to provide informed consent
- Refused consent
- Inappropriate for study enrollment per clinician
- Known to have a left ventricular assist device (LVAD)
- Research team unavailable
Who the study is looking for
- \>65 years old
- English speaking
- Must have one or more of the following:
- Chronic life-limiting illness with median survival \<2 years defined as: 1) metastatic cancer or inoperable lung cancer; 2) COPD requiring oxygen; 3) New York Heart Association Class III or IV heart failure, 4) Child's Class C cirrhosis or MELD score of \>20, 5) End-stage renal disease (must be on dialysis and ≥ 75 years old), 6) Advanced pulmonary fibrosis/interstitial lung disease, 7) Advanced pulmonary hypertension
- Severe functional impairment defined as dependence with \>4 activities of daily living (ADLs) on Katz Index of Independence in ADLs.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Vermont Coordinator of this site? Confirm its status | Burlington | United States | Unknown status |
| University of North Carolina Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
| Medical University of South Carolina Coordinator of this site? Confirm its status | Charleston | United States | Unknown status |
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.